FDA Output
FDA Output, March 2025
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in March 2025. Updated March 13, 2025.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
MedTech Innovator Presents
They Are the Champions
We interview some of the major medtech companies that mentor start-ups in the MedTech Innovator Accelerator, including Johnson & Johnson, Edwards Lifesciences, Olympus, and Dexcom. It turns out that the learning goes both ways.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: Trump Firings Hit CDRH
Mass firings hit the FDA's device center on February 15. Excerpted from Pathways’ Pick of the Week February 19: CDRH Staff Slashed, Signs of Medicare Rulemaking, China Approval Trends, and More.